Why Isn't Retatrutide Approved Yet?

This is why any form of exclusivity is a bad idea. The only ones who get hurt are patients and healthcare providers, twice, first by the delays and then higher prices for longer.

Patents should have switched to a royalty system the moment enforcing it was practical. And come with an exception for all non commercial use. It's never too late to fix.